The expected launch of daraxonrasib, a drug developed by Revolution Medicines, will likely deliver b...
A breakthrough in pancreatic cancer has experts excited — and braced for what’s to come
The expected launch of daraxonrasib, a drug developed by Revolution Medicines, will likely deliver both opportunities and challenges.
Author: STAT
Read Original Article